GH1 and adenoma: Clinical, biochemical, radiological, and treatment outcomes were compared across groups.<h4>Results</h4>Of 90 adenomas, 47 (52.2%) were GH-only, 39 (43.3%) GH/PRL, and 4 (4.4%) other PIT-1 lineage adenomas.